Tirzepatide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should not be used during pregnancy due to potential fetal harm
CVD includes heart disease, heart failure, stroke, and peripheral arterial disease
The temples gradually move upward, creating an M-shaped hairline
Unlike semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP), the additional glucagon receptor layer drives hepatic fat oxidation and increases resting energy expenditure through a mechanism that works independently of appetite suppression
Additional promising targets include TGF--driven fibrogenic signaling and oxidative stress pathways propagated by advanced glycation end-products and their receptor RAGE (Zhou et al., 2025b), IL-6 neutralization (ziltivekimab), and anti-fibrotic candidates like pirfenidone or ASK1 inhibition (selonsertib) (Figure 6)